ViroMed Introduces Molecular Tests for Rapid Diagnosis of Respiratory Viruses Including Avian Flu
Real-time PCR Test Quickly Detects and Differentiates the H5N1 Avian Flu Strain from Other More Common Respiratory Virus Strains
"The addition of these tests further enhances ViroMed's comprehensive respiratory pathogen test menu," noted Myla Lai-Goldman, M.D., Executive Vice President, Chief Scientific Officer and Medical Director of LabCorp. "These rapid molecular tests detect the presence of common influenzas and other respiratory pathogens, while providing specific typing information for strains such as the H5N1 avian flu strain. As flu season approaches and concerns about avian flu mount, the level of detailed information these tests provide will be useful for the surveillance and monitoring of influenza activity. Faster diagnosis also leads to appropriate and cost effective antiviral treatment sooner, and brings peace of mind to physicians and their patients by expeditiously identifying the cause."
The ViroMed laboratory has served as a testing center for antiviral drug resistance studies in influenza strains isolated globally. In addition to PCR-based assays, ViroMed also has the capabilities to detect respiratory pathogens using more traditional assays such as rapid and standard culture methods and antibody-based detection methods.
Organizations
Other news from the department research and development
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.